Basic Information
| LncRNA/CircRNA Name | CRNDE |
| Synonyms | NA |
| Region | GRCh38_16:54845189-54929189 |
| Ensemble | ENSG00000245694 |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | wilms tumor |
| ICD-0-3 | C64.9 |
| Methods | RT-qPCR |
| Sample | Wilms??umor tissues,cell Lines |
| Expression Pattern | up-regulated |
| Function Description | CRNDE was highly expressed in Wilms' tumor tissue and cell lines. The expression of CRNDE was correlated with the incidence rate of lymph node metastasis in patients with Wilms' tumor. In addition, CRNDE might accelerate the progression of Wilms' tumor via modulating microRNA-424. |
| Pubmed ID | 32096178 |
| Year | 2020 |
| Title | LncRNA CRNDE promotes the development of Wilms' tumor by regulating microRNA-424 |
External Links
| Links for CRNDE | GenBank HGNC NONCODE |
| Links for wilms tumor | OMIM COSMIC |